Gene Ontology annotation through association of InterPro records with GO terms.
Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity.
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping
Gene Ontology annotation based on curation of immunofluorescence data
Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara.
Electronic Gene Ontology annotations created by ARBA machine learning models
Combined Automated Annotation using Multiple IEA Methods.
Using a biochemical approach to identify the primary dimerization regions in human DNA topoisomerase IIalpha.
Human topoisomerase IIalpha and IIbeta interact with the C-terminal region of p53.
Mutagenesis of E477 or K505 in the B' domain of human topoisomerase II beta increases the requirement for magnesium ions during strand passage.
-
Direct biochemical characterization of human TOP2B
-
Magnesium ions required for strand passage activity
-
TOPRIM domain residues critical for catalysis
Histone deacetylase interacts directly with DNA topoisomerase II.
Deacetylase activity associates with topoisomerase II and is necessary for etoposide-induced apoptosis.
Protein kinase C delta activates topoisomerase IIalpha to induce apoptotic cell death in response to DNA damage.
A study of the topoisomerase II activity in HIV-1 replication using the ferrocene derivatives as probes.
Nuclear interactions of topoisomerase II alpha and beta with phospholipid scramblase 1.
-
TOP2B interacts with PLSCR1
-
PLSCR1 increases TOP2 decatenation activity
-
C-terminal region of TOP2 required for interaction
Mutations in topoisomerase IIβ result in a B cell immunodeficiency.
-
TOP2B mutations cause BILU syndrome
-
Dominant negative mutations in TOPRIM domain
-
Complete absence of B cells in patients
-
Mutations reduce enzyme activity more than 10-fold
Topoisomerase 2β mutation impairs early B-cell development.
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
Discrete localization of different DNA topoisomerases in HeLa and K562 cell nuclei and subnuclear fractions.
Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities.
-
TOP2B excluded from nucleoli during interphase
-
TOP2B released to cytosol during mitosis
-
TOP2B binds chromatin differently than TOP2A
-
Detailed immunofluorescence characterization
The distribution and expression of the two isoforms of DNA topoisomerase II in normal and neoplastic human tissues.
SUMOylation of TOP2B with SUMO1
-
TOP2B is SUMOylated
-
Occurs in nucleoplasm
Deep research on TOP2B function
-
Comprehensive review of TOP2B functions
-
Core enzyme activity
-
B cell development role
-
Neuronal functions
-
TAD boundary organization
-
ATP-dependent localization regulation
Falcon (Edison Scientific Literature) deep research report on human TOP2B (Q02880)
-
Catalytic mechanism: ATP-dependent strand passage with transient
enzyme-bridged DSB at G-DNA gate, T-DNA transport, religation, ATP
hydrolysis-driven cycle reset.
"DNA topoisomerase IIβ (TOP2B) is a type II topoisomerase that
changes DNA topology by an ATP-dependent strand-passage reaction.
Mechanistically, one duplex DNA segment (G-DNA, gate) is
transiently cleaved to create an enzyme-bridged break, and a
second duplex (T-DNA, transported) is passed through; the G-DNA
is then religated, and ATP hydrolysis resets the enzyme cycle.
"
-
N-terminal ATPase domain adopts Bergerat/GHKL fold; E103 is the
catalytic base; Km for ATP ~0.115 mM (45-444 ATPase construct).
"The N-terminal ATPase domain has a Bergerat/GHKL fold; E103 acts
as a catalytic base for ATP hydrolysis (E103A abolishes ATP
hydrolysis). Reported ATPase kinetic parameters
(construct-dependent): e.g., Km ~0.115 mM for ATP for a 45-444
ATPase-domain construct.
"
-
C-terminal domain (CTD) contains nuclear localization signals and
many phosphorylation sites, consistent with nuclear chromatin
function.
"TOP2B is primarily a nuclear enzyme. Structural work on human
TOP2B states that the C-terminal domain contains nuclear
localization signals and many phosphorylation sites, consistent
with nuclear chromatin-associated function.
"
-
TOP2Bcc-seq (etoposide-trapped covalent complexes) in cortical
neurons identifies 35,505 peaks; depleted at promoters/TSSs and
enriched across gene bodies and active chromatin states.
"Experimental trapping condition: etoposide 50 μM for 30 min.
Genome-wide called peaks: n = 35,505. Distribution: TOP2B
catalytic engagement is relatively depleted at promoters/TSSs and
enriched across gene bodies and active chromatin/transcription
states.
"
-
Catalytic engagement, not mere binding, defines TOP2B function;
TOP2Bcc-seq correlates with prior TOP2B ChIP-seq (Spearman 0.64)
but emphasizes catalytic deployment within transcribed regions.
"Agreement with occupancy mapping: TOP2Bcc-seq correlated with
prior TOP2B ChIP-seq (Spearman 0.64) but shows distinct
distribution emphasizing catalytic engagement rather than mere
binding. These results support a model where TOP2B's catalytic
function is frequently deployed within transcribed regions to
manage topological constraints rather than being limited to
promoter-localized binding.
"
-
TOP2B activity correlates with chromosomal compartment
organization and nucleosome configuration in neurons; engagement
occurs at architectural sites including CTCF/cohesin.
"TOP2B catalytic engagement and/or binding has been reported to
occur in open chromatin and at architectural protein sites
(CTCF/cohesin) in neurons. The 2024 mapping study reports TOP2B
activity correlates with chromosomal compartment organization and
nucleosome configuration.
"
-
Neuronal stimulation can increase TOP2B association/activation at
immediate early genes (e.g., 5-fold NMDA-induced); calcineurin
dephosphorylation regulates activity-induced TOP2B breaks.
"A 2024 review synthesizing the field notes that neuronal
stimulation can increase TOP2B association/activation at
immediate early genes, with a reported five-fold increase in
IEG-bound TOP2B upon NMDA stimulation in cited work; the same
review also describes calcineurin-dependent regulation (Ca2+
influx → calcineurin → TOP2B dephosphorylation) of
activity-induced breaks.
"
-
AD brains show 19.9-fold more global PAR peaks but loss of
adaptive breaks at nervous-system genes; TOP2B-positive cells are
markedly reduced in AD vs control cortex (21.7 vs 82.4).
"AD brains contained 19.9× more PAR peaks than non-demented
brains. Yet adaptive breaks at nervous-system genes were
"profoundly lost" and gene expression downregulated. TOP2B-positive
cells by IHC quantification (3 ND vs 3 AD): 82.4 ± 7.0 (ND) vs
21.7 ± 9.3 (AD), p < 0.05.
"
-
TOP2B is mechanistically implicated in anthracycline (e.g.,
doxorubicin) cardiotoxicity; disruption of TOP2B in iPSC-CMs
reduces doxorubicin sensitivity.
"The paper notes that TOP2B is essential for cardiotoxicity in
mouse models and that disruption of TOP2B in iPSC-CMs can reduce
doxorubicin sensitivity (reported as background/interpretive
context).
"
A comprehensive structural analysis of the ATPase domain of human DNA topoisomerase II beta bound to AMPPNP, ADP, and the bisdioxopiperazine, ICRF193.
-
TOP2B modulates DNA topology using energy from ATP hydrolysis.
"Human topoisomerase II beta (TOP2B) modulates DNA topology using
energy from ATP hydrolysis.
"
-
Residue E103 is essential for ATP hydrolysis in TOP2B
(mutagenesis evidence).
"Mutagenesis demonstrated residue E103 as essential for ATP
hydrolysis in TOP2B.
"
-
The N-terminal strap reduces the rate of ATP hydrolysis;
structural characterization included AMPPNP, ADP, and ICRF193
complexes.
"Biochemical characterization revealed the N-terminal strap
reduces the rate of ATP hydrolysis.
"
Mapping catalytically engaged TOP2B in neurons reveals the principles of topoisomerase action within the genome.
-
Catalytically engaged TOP2B (TOP2Bcc) was trapped in covalent
DNA cleavage complexes and mapped genome-wide in cultured mouse
cortical neurons.
"We trapped catalytically engaged topoisomerase IIβ (TOP2B) in
covalent DNA cleavage complexes (TOP2Bccs) and mapped their
positions genome-wide in cultured mouse cortical neurons.
"
-
TOP2Bcc distribution scales with transcription level in gene
bodies and varies with nucleosome and compartmental chromosome
organization, indicating coupling of catalytic engagement to
transcription and chromatin context.
"TOP2Bcc distribution varies with both nucleosome and
compartmental chromosome organization. While TOP2Bccs in gene
bodies correlate with their level of transcription.
"
-
Catalytic engagement is curtailed at active promoters despite
high TOP2B ChIP-seq signal there, indicating that
binding/occupancy does not equal catalytic activity.
"Promoters with high RNA polymerase II occupancy show elevated
TOP2B chromatin immunoprecipitation sequencing signals but low
TOP2Bccs, indicating that TOP2B catalytic engagement is
curtailed at active promoters.
"
-
TOP2B poisoning/inhibition increases nascent transcription at
most genes/enhancers but reduces transcription within long
genes, correlating with intragenic enhancers rather than length.
"Surprisingly, either poisoning or inhibiting TOP2B increases
nascent transcription at most genes and enhancers but reduces
transcription within long genes. These effects are independent
of transcript length and instead correlate with the presence of
intragenic enhancers.
"
Loss of Adaptive DNA Breaks in Alzheimer's Disease Brains.
-
AD frontal cortex shows 19.9-fold global increase in PAR peaks
but loss of adaptive breaks at nervous-system genes.
"AD brains contained 19.9× more PAR peaks than non-demented brains.
Yet adaptive breaks at nervous-system genes were "profoundly lost"
and gene expression downregulated.
"
-
TOP2B-positive cell counts are markedly reduced in AD cortex
versus controls (21.7 ± 9.3 vs 82.4 ± 7.0, p<0.05), suggesting
impaired TOP2B-linked break physiology.
"TOP2B-positive cells by IHC quantification (3 ND vs 3 AD):
82.4 ± 7.0 (ND) vs 21.7 ± 9.3 (AD), p < 0.05.
"
Adaptive and Maladaptive DNA Breaks in Neuronal Physiology and Alzheimer's Disease.
-
Neuronal stimulation increases TOP2B association at immediate
early genes (~5-fold with NMDA); calcineurin-mediated
dephosphorylation regulates activity-induced TOP2B breaks.
"A 2024 review synthesizing the field notes that neuronal
stimulation can increase TOP2B association/activation at
immediate early genes, with a reported five-fold increase in
IEG-bound TOP2B upon NMDA stimulation in cited work; the same
review also describes calcineurin-dependent regulation (Ca2+
influx → calcineurin → TOP2B dephosphorylation) of
activity-induced breaks.
"
Anthracyclines induce cardiotoxicity through a shared gene expression response signature.
-
TOP2B is essential for anthracycline-induced cardiotoxicity in
mouse models; TOP2B disruption in iPSC-cardiomyocytes reduces
doxorubicin sensitivity.
"The paper notes that TOP2B is essential for cardiotoxicity in
mouse models and that disruption of TOP2B in iPSC-CMs can reduce
doxorubicin sensitivity (reported as background/interpretive
context).
"
-
TOP2 inhibitors elicit broad shared transcriptional responses in
iPSC-CMs; median LD50 (μM): DOX 14.02, DNR 0.98, EPI 3.79,
MTX 0.98.
"Median LD50 (μM): DOX 14.02, DNR 0.98, EPI 3.79, MTX 0.98.
"
Evolution of Theories on Doxorubicin-Induced Late Cardiotoxicity - Role of Topoisomerase.
-
TOP2B is highlighted as the mechanistic basis for anthracycline
late cardiotoxicity; dose-risk thresholds include ~5% CHF at
400 mg/m2 doxorubicin and >35% dilated cardiomyopathy at
650 mg/m2.
"Cumulative doxorubicin thresholds and risks: ~5% cardiomyopathy/CHF
at 400 mg/m², and elevated incidence at higher cumulative doses;
the review also cites >35% incidence of dilated cardiomyopathy at
650 mg/m² and notes thresholds ~550 mg/m² (or 450 mg/m² with
additional risks).
"